Amgen stock on watch as JPMorgan conference speech looms after two-day slide
Amgen shares fell 1.21% to $326.10 Friday, extending a two-day slide. The drop comes ahead of CEO Robert Bradway’s scheduled remarks Monday at the J.P. Morgan Healthcare Conference. Investors are watching for updates after Amgen announced two oncology deals and received a UBS upgrade to Buy with a $380 price target.